• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国武汉青山区武汉钢铁公司第二医院新型冠状病毒肺炎病例分析

Case analysis of novel coronavirus pneumonia in the Second Hospital of Wuhan Iron and Steel Company, Qingshan District, Wuhan, China.

作者信息

Liu Meirong, Lyu Yang, Zhao Wenchang, Yu Shuang, Shi Dongsheng, Lu Wei

机构信息

Department of Infectious Diseases, Tianjin Hospital, Tianjin, China.

Department of Intensive Care Unit, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.

出版信息

Ann Palliat Med. 2020 Jul;9(4):2193-2202. doi: 10.21037/apm-20-1372. Epub 2020 Jul 20.

DOI:10.21037/apm-20-1372
PMID:32692241
Abstract

BACKGROUND

To analyze the clinical and infectious characteristics of new coronavirus pneumonia with diagnosed and suspected cases in the Second Hospital of WISCO(Wuhan Iron and Steel Company) of Qingshan District, Wuhan City, and further enhance the understanding of new coronavirus pneumonia.

METHODS

According to the fifth and sixth editions of the new coronavirus pneumonia diagnosis and treatment plan issued by the National Health Commission of the People's Republic of China and National Administration of Traditional Chinese Medicine, we carried out the case analysis and infectious disease investigation and research on the confirmed and suspected cases of new coronavirus pneumonia admitted to the second-floor ward of the hospital from January 28th, 2020, to February 26th, 2020.

RESULTS

From January 28th, 2020 to February 26th, 2020, 83 patients were admitted, 40 were cured, and 7 died. Before February 13th, 69 patients were admitted, including 22 confirmed patients and 47 suspected patients. After February 13th, the data of newly hospitalized suspected patients decreased to 2 people. The average time from onset to diagnosis was 5.38 days. About 57.1% of the confirmed patients were isolated at home before admission, and 53.2% of the suspected patients were isolated by hospital observation before admission. The proportion of fever and other clinical symptoms was 81.8%, 65.5% of the patients had the fastest heart rate of 90-120 rpm, and 11 of the patients had severe/critical illness, accounting for 20%. The count of leukocytes, neutrophils, and C-reactive proteins (CRPs) in severe patients was higher than those in light patients (P<0.05), and the count of lymphocytes was lower than that in mild patients (P=0.016).

CONCLUSIONS

The novel coronavirus pneumonia in Qingshan District of Wuhan in February was diagnosed promptly, controlled,and treated effectively. The combination of traditional Chinese and western medicine in the treatment of new coronavirus pneumonia might help patients.

摘要

背景

分析武汉市青山区武汉钢铁公司第二医院确诊和疑似新型冠状病毒肺炎病例的临床及感染特征,进一步提高对新型冠状病毒肺炎的认识。

方法

依据中华人民共和国国家卫生健康委员会和国家中医药管理局发布的新型冠状病毒肺炎诊疗方案第五版和第六版,对2020年1月28日至2月26日期间收治于我院二楼病房的新型冠状病毒肺炎确诊及疑似病例进行病例分析及传染病调查研究。

结果

2020年1月28日至2月26日,共收治患者83例,治愈40例,死亡7例。2月13日前收治69例,其中确诊患者22例,疑似患者47例。2月13日后,新入院疑似患者数据降至2人。从发病到确诊的平均时间为5.38天。约57.1%的确诊患者在入院前居家隔离,53.2%的疑似患者在入院前接受医院观察隔离。发热等临床症状的比例为81.8%,65.5%的患者最快心率为90 - 120次/分钟,11例患者为重症/危重症,占20%。重症患者白细胞、中性粒细胞及C反应蛋白(CRP)计数高于轻症患者(P<0.05),淋巴细胞计数低于轻症患者(P = 0.016)。

结论

2月武汉市青山区新型冠状病毒肺炎得到及时诊断、控制及有效治疗。中西医结合治疗新型冠状病毒肺炎可能对患者有益。

相似文献

1
Case analysis of novel coronavirus pneumonia in the Second Hospital of Wuhan Iron and Steel Company, Qingshan District, Wuhan, China.中国武汉青山区武汉钢铁公司第二医院新型冠状病毒肺炎病例分析
Ann Palliat Med. 2020 Jul;9(4):2193-2202. doi: 10.21037/apm-20-1372. Epub 2020 Jul 20.
2
Clinical characteristics of coronavirus disease 2019 in Gansu province, China.中国甘肃省2019冠状病毒病的临床特征
Ann Palliat Med. 2020 Jul;9(4):1404-1412. doi: 10.21037/apm-20-887. Epub 2020 Jul 13.
3
Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis.中国武汉 95 例 2019 年新型冠状病毒肺炎的临床特征和实验室结果分析:回顾性分析。
Respir Res. 2020 Mar 26;21(1):74. doi: 10.1186/s12931-020-01338-8.
4
Mining the Characteristics of COVID-19 Patients in China: Analysis of Social Media Posts.挖掘中国新冠肺炎患者的特征:基于社交媒体帖子的分析
J Med Internet Res. 2020 May 17;22(5):e19087. doi: 10.2196/19087.
5
Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.中国湖南普通型 2019 冠状病毒病患者的临床特征和药物治疗方法。
Int J Clin Pharm. 2020 Jun;42(3):837-845. doi: 10.1007/s11096-020-01031-2. Epub 2020 May 14.
6
Characteristics of disease progress in patients with coronavirus disease 2019 in Wuhan, China.中国武汉 2019 冠状病毒病患者疾病进展的特征。
Epidemiol Infect. 2020 May 6;148:e94. doi: 10.1017/S0950268820000977.
7
[A single arm clinical study of 86 patients with common type of coronavirus disease 2019 treated by integrated traditional Chinese and Western medicine: multicenter case observation from 7 designated hospitals in Henan Province].[86例普通型新型冠状病毒肺炎患者中西医结合治疗的单臂临床研究:河南省7家定点医院多中心病例观察]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Aug;32(8):922-927. doi: 10.3760/cma.j.cn121430-20200528-00485.
8
Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China.中国上海 333 例新冠肺炎确诊病例的流行病学和临床特征。
Transbound Emerg Dis. 2020 Jul;67(4):1697-1707. doi: 10.1111/tbed.13604. Epub 2020 May 13.
9
Clinical characteristics of 71 patients with coronavirus disease 2019.71例2019冠状病毒病患者的临床特征
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 Jul 28;45(7):790-796. doi: 10.11817/j.issn.1672-7347.2020.200187.
10
Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病(COVID-19)住院儿科患者的临床和免疫特征。
JAMA Netw Open. 2020 Jun 1;3(6):e2010895. doi: 10.1001/jamanetworkopen.2020.10895.

引用本文的文献

1
Changes in clinical parameters and inflammatory markers after blood culture collection facilitate early identification of positive culture in adult patients with COVID-19 and clinically suspected bloodstream infection.血培养采集后临床参数和炎症标志物的变化有助于早期识别 COVID-19 成年患者和临床疑似血流感染的阳性培养。
J Int Med Res. 2024 Apr;52(4):3000605241238134. doi: 10.1177/03000605241238134.